Skip to main content
    • Aa
    • Aa

Age at onset of non-affective psychosis in relation to cannabis use, other drug use and gender

  • N. Dekker (a1), J. Meijer (a1), M. Koeter (a1) (a2), W. van den Brink (a1) (a2), N. van Beveren (a3), GROUP Investigators:, R. S. Kahn (a4), D. H. Linszen (a1), J. van Os (a5), D. Wiersma (a6), R. Bruggeman (a6), W. Cahn (a4), L. de Haan (a1), L. Krabbendam (a5) and I. Myin-Germeys (a5)...

Cannabis use is associated with an earlier age at onset of psychotic illness. The aim of the present study was to examine whether this association is confounded by gender or other substance use in a large cohort of patients with a non-affective psychotic disorder.


In 785 patients with a non-affective psychotic disorder, regression analysis was used to investigate the independent effects of gender, cannabis use and other drug use on age at onset of first psychosis.


Age at onset was 1.8 years earlier in cannabis users compared to non-users, controlling for gender and other possible confounders. Use of other drugs did not have an additional effect on age at onset when cannabis use was taken into account. In 63.5% of cannabis-using patients, age at most intense cannabis use preceded the age at onset of first psychosis. In males, the mean age at onset was 1.3 years lower than in females, controlling for cannabis use and other confounders.


Cannabis use and gender are independently associated with an earlier onset of psychotic illness. Our findings also suggest that cannabis use may precipitate psychosis. More research is needed to clarify the neurobiological factors that make people vulnerable to this precipitating effect of cannabis.

Corresponding author
*Address for correspondence: Dr L. de Haan, Department of Psychiatry, Academic Medical Centre, University of Amsterdam, Meibergdreef 5, 1105 AZ Amsterdam, The Netherlands. (Email:
Hide All
AddingtonJ, AddingtonD (2007). Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatrica Scandinavica 115, 304309.
AlemanA, KahnRS, SeltenJP (2003). Sex differences in the risk of schizophrenia: evidence from meta-analysis. Archives of General Psychiatry 60, 565571.
AndreasenNC, FlaumM, ArndtS (1992). The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. Archives of General Psychiatry 49, 615623.
APA (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th edn. American Psychiatric Association: Washington, DC.
BarnesTR, MutsatsaSH, HuttonSB, WattHC, JoyceEM (2006). Comorbid substance use and age at onset of schizophrenia. British Journal of Psychiatry 188, 237242.
BarnettJH, WernersU, SecherSM, HillKE, BrazilR, MassonK, PernetDE, KirkbrideJB, MurrayGK, BullmoreET, JonesPB (2007). Substance use in a population-based clinic sample of people with first-episode psychosis. British Journal of Psychiatry 190, 515520.
BarrigonML, GurpeguiM, Ruiz-VeguillaM, DiazFJ, AnguitaM, SarrameaF, CervillaJ (2010). Temporal relationship of first-episode non-affective psychosis with cannabis use: a clinical verification of an epidemiological hypothesis. Journal of Psychiatric Research 44, 413420.
BersaniG, OrlandiV, KotzalidisGD, PancheriP (2002). Cannabis and schizophrenia: impact on onset, course, psychopathology and outcomes. European Archives of Psychiatry and Clinical Neuroscience 252, 8692.
BradyKT, LydiardRB, MalcolmR, BallengerJC (1991). Cocaine-induced psychosis. Journal of Clinical Psychiatry 52, 509512.
BuhlerB, HambrechtM, LofflerW, an der HeidenW, HafnerH (2002). Precipitation and determination of the onset and course of schizophrenia by substance abuse – a retrospective and prospective study of 232 population-based first illness episodes. Schizophrenia Research 54, 243251.
CastleD, ShamP, MurrayR (1998). Differences in distribution of ages of onset in males and females with schizophrenia. Schizophrenia Research 33, 179183.
De HertM, WampersM, JendrickoT, FranicT, VidovicD, De VriendtN, SweersK, PeuskensJ, van WinkelR (2011). Effects of cannabis use on age at onset in schizophrenia and bipolar disorder. Schizophrenia Research 126, 270276.
DekkerN, de HaanL, BergS, GierM, BeckerH, LinzenDH (2008). Cessation of cannabis use by patients with recent-onset schizophrenia and related disorders. Psychopharmacology Bulletin 41, 142153.
DekkerN, SmeerdijkAM, WiersRW, DuitsJH, van GelderG, HoubenK, SchippersG, LinszenDH, de HaanL (2010). Implicit and explicit affective associations towards cannabis use in patients with recent-onset schizophrenia and healthy controls. Psychological Medicine 40, 13251336.
DeRosseP, KaplanA, BurdickKE, LenczT, MalhotraAK (2010). Cannabis use disorders in schizophrenia: effects on cognition and symptoms. Schizophrenia Research 120, 95–100.
Divisie Psychiatrie Academisch Ziekenhuis Utrecht (2003). Dutch Version of the Comprehensive Assessment of Symptoms and History (CASH). Divisie Psychiatrie Academisch Ziekenhuis Utrecht: Utrecht.
DragtS, NiemanDH, BeckerHE, van de FliertR, DingemansPM, de HaanL, van AmelsvoortTA, LinszenDH (2010). Age of onset of cannabis use is associated with age of onset of high-risk symptoms for psychosis. Canadian Journal of Psychiatry 55, 165171.
EstradaG, Fatjó-VilasM, MuñozMJ, PulidoG, MiñanoMJ, ToledoE, IllaJM, MartínM, MirallesML, MiretS, CampaneraS, BernabeuC, NavarroME, FañanásL (2011). Cannabis use and age at onset of psychosis: further evidence of interaction with COMT Val158Met polymorphism. Acta Psychiatrica Scandinavica 123, 485492.
FotiDJ, KotovR, GueyLT, BrometEJ (2010). Cannabis use and the course of schizophrenia: 10-year follow-up after first hospitalization. American Journal of Psychiatry 167, 987993.
GielR, NienhuisFJ (2001). SCAN 2.1: Dutch Version of the Schedules for Clinical Assessment in Neuropsychiatry. Harcourt Test Publishers: Amsterdam.
GoldbergerC, DervauxA, GourionD, BourdelMC, LôoH, LaqueilleX, KrebsMO (2010). Variable individual sensitivity to cannabis in patients with schizophrenia. International Journal of Neuropsychopharmacology 13, 11451154.
González-PintoA, VegaP, IbáñezB, MosqueraF, BarbeitoS, GutiérrezM, Ruiz de AzúaS, RuizI, VietaE (2008). Impact of cannabis and other drugs on age at onset of psychosis. Journal of Clinical Psychiatry 69, 12101216.
HafnerH (2003). Gender differences in schizophrenia. Psychoneuroendocrinology 28 (Suppl. 2), 1754.
HambrechtM, HäfnerH (1996). Substance abuse and the onset of schizophrenia. Biological Psychiatry 40, 11551163.
HambrechtM, MaurerK, HäfnerH, SartoriusN (1992). Translational stability of gender differences in schizophrenia? An analysis based on the WHO study on determinants of outcome of severe mental disorders. European Archives of Psychiatry and Clinical Neuroscience 242, 6–12.
KorverN, QueePJ, BoosH, SimonsCJP, Genetic Risk and Outcome of Psychosis (GROUP) Investigators (in press). Genetic Risk and Outcome of Psychosis (GROUP), a multi site longitudinal cohort study focused on gene-environment interaction: objectives, sample characteristics, recruitment and assessment methods. International Journal of Methods in Psychiatric Research.
LandabasoMA, IraurgiI, Jimenez-LermaJM, CalleR, SanzJ, Gutierrez-FraileM (2002). Ecstasy-induced psychotic disorder: six-month follow-up study. European Addiction Research 8, 133140.
LargeM, SharmaS, ComptonMT, SladeT, NielssenO (2011). Cannabis use and earlier onset of psychosis: a systematic meta-analysis. Archives of General Psychiatry 68, 555561.
LauronenE, MiettunenJ, VeijolaJ, KarhuM, JonesPB, IsohanniM (2007). Outcome and its predictors in schizophrenia within the Northern Finland 1966 Birth Cohort. European Psychiatry 22, 129136.
LeungA, ChueP (2000). Sex differences in schizophrenia, a review of the literature. Acta Psychiatrica Scandinavica. Supplementum 401, 338.
LinszenDH, DingemansPM, LeniorME (1994). Cannabis abuse and the course of recent-onset schizophrenic disorders. Archives of General Psychiatry 51, 273279.
MauriMC, VolonteriLS, De GaspriI, ColasantiA, BrambillaMA, CerrutiL (2006). Substance abuse in first-episode schizophrenic patients: a retrospective study. Clinical Practice and Epidemiology in Mental Health 2, 4.
McKetinR, McLarenJ, LubmanDI, HidesL (2006). The prevalence of psychotic symptoms among methamphetamine users. Addiction 101, 14731478.
OngurD, LinL, CohenBM (2009). Clinical characteristics influencing age at onset in psychotic disorders. Comprehensive Psychiatry 50, 1319.
Pelayo-TeránJM, Pérez-IglesiasR, MataI, Carrasco-MarinE, Vazquez-BarqueroJL, Crespo-FacorroB (2010). Catechol-O-Methyltransferase (COMT) Val158Met variations and cannabis use in first-episode non-affective psychosis: clinical-onset implications. Psychiatry Research 179, 291296.
RabinowitzJ, LevineSZ, HafnerH (2006). A population based elaboration of the role of age of onset on the course of schizophrenia. Schizophrenia Research 88, 96–101.
SatelSL, SouthwickSM, GawinFH (1990). Clinical features of cocaine induced paranoia. National Institute on Drug Abuse Research Monograph 105, 371.
SevyS, RobinsonDG, NapolitanoB, PatelRC, Gunduz-BruceH, MillerR, McCormackJ, LorellBS, KaneJ (2010). Are cannabis use disorders associated with an earlier age at onset of psychosis? A study in first episode schizophrenia. Schizophrenia Research 120, 101107.
SugranyesG, FlamariqueI, ParelladaE, BaezaI, GotiJ, Fernandez-EgeaE, BernardoM (2009). Cannabis use and age of diagnosis of schizophrenia. European Psychiatry 24, 282286.
SzymanskiS, LiebermanJA, AlvirJM, MayerhoffD, LoebelA, GeislerS, ChakosM, KoreenA, JodyD, KaneJ (1995). Gender differences in onset of illness, treatment response, course, and biologic indexes in first-episode schizophrenic patients. American Journal of Psychiatry 152, 698703.
VardyMM, KaySR (1983). LSD psychosis or LSD-induced schizophrenia? A multimethod inquiry. Archives of General Psychiatry 40, 877883.
VeenND, SeltenJP, van der TweelI, FellerWG, HoekHW, KahnRS (2004). Cannabis use and age at onset of schizophrenia. American Journal of Psychiatry 161, 501506.
WHO (1994). Composite International Diagnostic Interview: Researchers' Manual. World Health Organization: Geneva.
WingJK, BaborT, BrughaT, BurkeJ, CooperJE, GielR, JablenskiA, RegierD, SartoriusN (1990). SCAN. Schedules for Clinical Assessment in Neuropsychiatry. American Journal of Psychiatry 47, 589593.
Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Psychological Medicine
  • ISSN: 0033-2917
  • EISSN: 1469-8978
  • URL: /core/journals/psychological-medicine
Please enter your name
Please enter a valid email address
Who would you like to send this to? *



Altmetric attention score

Full text views

Total number of HTML views: 7
Total number of PDF views: 36 *
Loading metrics...

Abstract views

Total abstract views: 388 *
Loading metrics...

* Views captured on Cambridge Core between September 2016 - 21st October 2017. This data will be updated every 24 hours.